These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26931004)

  • 1. [THE FEATURES OF SECRETION AND STOMACH MOTOR PROCESSES IN PATIENTS WITH DUODENAL ULCERS AS A CAUSE FOR REDUCING BIOAVAILABILITY OF PROTON PUMP INHIBITORS].
    Serebrova SY; Zhuravleva MV; Prokofiev AB; Starodubtsey A K
    Eksp Klin Gastroenterol; 2015; (9):8-13. PubMed ID: 26931004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the pharmacology of acid control in acid-related disorders.
    Howden CW
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):17S-19S; discussion 19S-21S. PubMed ID: 9127622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative assessment of gastric secretory function using a probe method and intragastric Ph-metry].
    Medvedev VN; Zelenskaia LM; Orlovskiĭ VF; Dotsenko NIa; Medvedeva VN; Protsenko NN; Kriukova TM
    Klin Med (Mosk); 1990 Mar; 68(3):89-92. PubMed ID: 2370764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Omeprazol and ezomeprazol pharmacokinetics, duration of antisecretory effect, and reasons for their probable changes in duodenal ulcer].
    Serebrova SIu; Starodubtsev AK; Pisarev VV; Kondratenko SN; Vasilenko GF; Dobrovol'skiĭ OV
    Eksp Klin Gastroenterol; 2009; (4):86-92. PubMed ID: 19960999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases].
    Rapoport SI; Khutsishvili MB; Rasulov MI; Trubitsina IE; Raĭkhlin NT
    Ter Arkh; 2008; 80(2):86-9. PubMed ID: 18372605
    [No Abstract]   [Full Text] [Related]  

  • 9. 24-h recording of intragastric pH: technical aspects and clinical relevance.
    van Herwaarden MA; Samsom M; Smout AJ
    Scand J Gastroenterol Suppl; 1999; 230():9-16. PubMed ID: 10499456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antisecretory effects of quamatel and gastrocepin in duodenal ulcer: comparison with intragastric pH-metry].
    Sheptulin AA; Okhlobystin AV
    Klin Med (Mosk); 1998; 76(8):38-40. PubMed ID: 9770967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release floating drug delivery system for proton pump inhibitors lansoprazole: In-vitro, In-vivo floating and pharmacokinetic evaluation.
    Murad S; Mudassir J; Faiz S; Zahra A; Usman F; Farhan M; Arshad MS; Abbas N; Hussain A; Faran Ashraf Baig MM
    Pak J Pharm Sci; 2022 Jan; 35(1(Supplementary)):195-201. PubMed ID: 35228177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of hyperbaric oxygenation on the secretory, motor function and microcirculation of the stomach and duodenal walls in patients with duodenal ulcers].
    Orlov VA; Shamkhalov ZM; Nugaeva NR
    Ter Arkh; 1992; 64(2):56-9. PubMed ID: 1509385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.
    Kirchheiner J; Glatt S; Fuhr U; Klotz U; Meineke I; Seufferlein T; Brockmöller J
    Eur J Clin Pharmacol; 2009 Jan; 65(1):19-31. PubMed ID: 18925391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral buffered esomeprazole is superior to i.v. pantoprazole for rapid rise of intragastric pH: a wireless pH metry analysis.
    Banerjee R; Reddy DN; Guda NM; Kalpala R; Mahurkar S; Darisetty S; Rao GV
    J Gastroenterol Hepatol; 2010 Jan; 25(1):43-7. PubMed ID: 19874444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials.
    Hu ZH; Shi AM; Hu DM; Bao JJ
    Saudi J Gastroenterol; 2017; 23(1):11-19. PubMed ID: 28139495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
    Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of different omeprazole dosing on gastric pH in non-variceal upper gastrointestinal bleeding: A randomized prospective study.
    Chwiesko A; Charkiewicz R; Niklinski J; Luczaj W; Skrzydlewska E; Milewski R; Baniukiewicz A; Wroblewski E; Rosolowski M; Dabrowski A
    J Dig Dis; 2016 Sep; 17(9):588-599. PubMed ID: 27518195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer].
    Kolesnikova IIu; Beliaeva GS; Bordin DS
    Klin Med (Mosk); 2002; 80(2):54-6. PubMed ID: 11898725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
    Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.